Literature DB >> 21558270

NF-kappaB signal triggering and termination by tumor necrosis factor receptor 2.

Montserrat Rodríguez1, Lucía Cabal-Hierro, María Teresa Carcedo, Juan Manuel Iglesias, Noelia Artime, Bryant G Darnay, Pedro S Lazo.   

Abstract

Tumor necrosis factor receptor 2 (TNFR2) activates transcription factor κB (NF-κB) and c-Jun N-terminal kinase (JNK). The mechanisms mediating these activations are dependent on the recruitment of TNF receptor-associated factor 2 (TRAF2) to the intracellular region of the receptor. TNFR2 also induces TRAF2 degradation. We show that in addition to the well characterized TRAF2 binding motif 402-SKEE-405, the human receptor contains another sequence located at the C-terminal end (amino acids 425-439), which also recruits TRAF2 and activates NF-κB. In addition to that, human TNFR2 contains a conserved region (amino acids 338-379) which is responsible for TRAF2 degradation and therefore of terminating NF-κB signaling. TRAF2 degradation and the lack of NF-κB activation when both TNFR1 and TNFR2 are co-expressed results in an enhanced ability of TNFR1 to induce cell death, showing that the cross-talk between both receptors is of a great biological relevance. Induction of TRAF2 degradation appears to be independent of TRAF2 binding to the receptor. Amino acids 343-TGSSDSS-349 are essential for inducing TRAF2 degradation because deletion mutants of this region or point mutations at serine residues 345 and 346 or 348 and 349 obliterate the ability of TNFR2 to induce TRAF2 degradation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21558270      PMCID: PMC3123049          DOI: 10.1074/jbc.M111.225631

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain.

Authors:  L Deng; C Wang; E Spencer; L Yang; A Braun; J You; C Slaughter; C Pickart; Z J Chen
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

2.  TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2.

Authors:  Xiaoming Li; Yili Yang; Jonathan D Ashwell
Journal:  Nature       Date:  2002-03-21       Impact factor: 49.962

3.  Etk/Bmx as a tumor necrosis factor receptor type 2-specific kinase: role in endothelial cell migration and angiogenesis.

Authors:  Shi Pan; Ping An; Rong Zhang; Xiangrong He; Guoyong Yin; Wang Min
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

4.  Caveolin-1 associates with TRAF2 to form a complex that is recruited to tumor necrosis factor receptors.

Authors:  X Feng; M L Gaeta; L A Madge; J H Yang; J R Bradley; J S Pober
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

5.  Tumor necrosis factor (TNF)-induced germinal center kinase-related (GCKR) and stress-activated protein kinase (SAPK) activation depends upon the E2/E3 complex Ubc13-Uev1A/TNF receptor-associated factor 2 (TRAF2).

Authors:  Chong-Shan Shi; John H Kehrl
Journal:  J Biol Chem       Date:  2003-02-18       Impact factor: 5.157

Review 6.  Tumor necrosis factor receptor-associated factors (TRAFs).

Authors:  J R Bradley; J S Pober
Journal:  Oncogene       Date:  2001-10-01       Impact factor: 9.867

7.  The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.

Authors:  Andrew Kovalenko; Christine Chable-Bessia; Giuseppina Cantarella; Alain Israël; David Wallach; Gilles Courtois
Journal:  Nature       Date:  2003-08-14       Impact factor: 49.962

8.  A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway.

Authors:  Tewis Bouwmeester; Angela Bauch; Heinz Ruffner; Pierre-Olivier Angrand; Giovanna Bergamini; Karen Croughton; Cristina Cruciat; Dirk Eberhard; Julien Gagneur; Sonja Ghidelli; Carsten Hopf; Bettina Huhse; Raffaella Mangano; Anne-Marie Michon; Markus Schirle; Judith Schlegl; Markus Schwab; Martin A Stein; Andreas Bauer; Georg Casari; Gerard Drewes; Anne-Claude Gavin; David B Jackson; Gerard Joberty; Gitte Neubauer; Jens Rick; Bernhard Kuster; Giulio Superti-Furga
Journal:  Nat Cell Biol       Date:  2004-01-25       Impact factor: 28.824

Review 9.  Tumor necrosis factor signaling.

Authors:  H Wajant; K Pfizenmaier; P Scheurich
Journal:  Cell Death Differ       Date:  2003-01       Impact factor: 15.828

10.  Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8.

Authors:  Mariola Fotin-Mleczek; Frank Henkler; Dierk Samel; Monica Reichwein; Angelika Hausser; Ingela Parmryd; Peter Scheurich; Johannes A Schmid; Harald Wajant
Journal:  J Cell Sci       Date:  2002-07-01       Impact factor: 5.285

View more
  24 in total

1.  Herpesvirus entry mediator (HVEM) attenuates signals mediated by the lymphotoxin β receptor (LTβR) in human cells stimulated by the shared ligand LIGHT.

Authors:  John Bechill; William J Muller
Journal:  Mol Immunol       Date:  2014-06-28       Impact factor: 4.407

2.  Both internalization and AIP1 association are required for tumor necrosis factor receptor 2-mediated JNK signaling.

Authors:  Weidong Ji; Yonghao Li; Ting Wan; Jing Wang; Haifeng Zhang; Hong Chen; Wang Min
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-06-28       Impact factor: 8.311

3.  Tumor necrosis factor receptor 2 (TNFR2)·interleukin-17 receptor D (IL-17RD) heteromerization reveals a novel mechanism for NF-κB activation.

Authors:  Shigao Yang; Yinyin Wang; Kunrong Mei; Sen Zhang; Xiaojun Sun; Fangli Ren; Sihan Liu; Zi Yang; Xinquan Wang; Zhihai Qin; Zhijie Chang
Journal:  J Biol Chem       Date:  2014-11-05       Impact factor: 5.157

4.  Cytokine TNF-α and its receptors TNFRI and TNFRII play a key role in the in vitro proliferative response of BLV infected animals.

Authors:  Pamela Anahí Lendez; Lucía Martinez-Cuesta; María Victoria Nieto Farias; Guillermina Laura Dolcini; María Carolina Ceriani
Journal:  Vet Res Commun       Date:  2021-08-27       Impact factor: 2.459

5.  Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2.

Authors:  Alexander Ungewickell; Aparna Bhaduri; Eon Rios; Jason Reuter; Carolyn S Lee; Angela Mah; Ashley Zehnder; Robert Ohgami; Shashikant Kulkarni; Randall Armstrong; Wen-Kai Weng; Dita Gratzinger; Mahkam Tavallaee; Alain Rook; Michael Snyder; Youn Kim; Paul A Khavari
Journal:  Nat Genet       Date:  2015-08-10       Impact factor: 38.330

6.  Release of nonmuscle myosin II from the cytosolic domain of tumor necrosis factor receptor 2 is required for target gene expression.

Authors:  Unni M Chandrasekharan; Lisa Dechert; Uchechukwu I Davidson; Matthew Waitkus; Lori Mavrakis; Katherine Lyons; Jordan R Beach; Xiaoxia Li; Thomas T Egelhoff; Paul L Fox; Paul E DiCorleto
Journal:  Sci Signal       Date:  2013-07-16       Impact factor: 8.192

7.  Effect of Exercise or Metformin on Biomarkers of Inflammation in Breast and Colorectal Cancer: A Randomized Trial.

Authors:  Justin C Brown; Sui Zhang; Jennifer A Ligibel; Melinda L Irwin; Lee W Jones; Nancy Campbell; Michael N Pollak; Alexandra Sorrentino; Brenda Cartmel; Maura Harrigan; Sara M Tolaney; Eric P Winer; Kimmie Ng; Thomas A Abrams; Tara Sanft; Pamela S Douglas; Frank B Hu; Charles S Fuchs; Jeffrey A Meyerhardt
Journal:  Cancer Prev Res (Phila)       Date:  2020-08-28

8.  Autophagy of metallothioneins prevents TNF-induced oxidative stress and toxicity in hepatoma cells.

Authors:  Chiara Ullio; Ulf T Brunk; Chiara Urani; Pasquale Melchioretto; Gabriella Bonelli; Francesco M Baccino; Riccardo Autelli
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

9.  Endogenous Transmembrane TNF-Alpha Protects Against Premature Senescence in Endothelial Colony Forming Cells.

Authors:  Linden A Green; Victor Njoku; Julie Mund; Jaime Case; Mervin Yoder; Michael P Murphy; Matthias Clauss
Journal:  Circ Res       Date:  2016-04-13       Impact factor: 17.367

10.  TNF-α impairs EP4 signaling through the association of TRAF2-GRK2 in primary fibroblast-like synoviocytes.

Authors:  Yu Tai; Bei Huang; Pai-Pai Guo; Zhen Wang; Zheng-Wei Zhou; Man-Man Wang; Han-Fei Sun; Yong Hu; Sheng-Lin Xu; Ling-Ling Zhang; Qing-Tong Wang; Wei Wei
Journal:  Acta Pharmacol Sin       Date:  2021-04-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.